Article
Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH
2021-09-14
Abstract excerpt
The role of EGFR in lung cancer is well described with numerous activating mutations that result in phosphorylation and tyrosine kinase inhibitors that target EGFR. While the role of the EGFR kinase in non-small cell lung cancer (NSCLC) is appreciated, control of EGFR signaling pathways through dephosphorylation by phosphatases is not as clear. In recent work we identified mutations in Protein Tyrosine Phosphatase...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9b060fdd-45cf-5cb6-ba10-faaab8d8c76a
- DOI
- 10.1101/2021.09.14.460311
